Filing Details
- Accession Number:
- 0001104659-15-051497
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-16 18:05:40
- Reporting Period:
- 2015-07-16
- Filing Date:
- 2015-07-16
- Accepted Time:
- 2015-07-16 18:05:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1356576 | Supernus Pharmaceuticals Inc | SUPN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219844 | S Gregory Patrick | C/O Supernus Pharmaceuticals, Inc. 1550 East Gude Drive Rockville MD 20850 | Vp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-07-16 | 6,217 | $20.00 | 7,344 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2015.
- Includes an aggregate of 1,127 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.